These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9210915)

  • 21. [First Scandinavian Gaucher meeting. Treatment with enzyme substitution provides optimism for the future].
    Stolt CM
    Nord Med; 1992; 107(11):292-3, 298. PubMed ID: 1448346
    [No Abstract]   [Full Text] [Related]  

  • 22. Alglucerase: the debate continues.
    Push S
    Pharmacoeconomics; 1995 Mar; 7(3):268-9. PubMed ID: 10155316
    [No Abstract]   [Full Text] [Related]  

  • 23. [The treatment of Gaucher's disease in The Netherlands using enzyme substitution therapy].
    Hollak CE; van Oers MH; Maaswinkel P; Aerts JM; Goudsmit R
    Ned Tijdschr Geneeskd; 1996 May; 140(19):1011-3. PubMed ID: 8684492
    [No Abstract]   [Full Text] [Related]  

  • 24. Home treatment with intravenous enzyme replacement therapy for Gaucher disease: an international collaborative study of 33 patients.
    Zimran A; Hollak CE; Abrahamov A; van Oers MH; Kelly M; Beutler E
    Blood; 1993 Aug; 82(4):1107-9. PubMed ID: 8353277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurological outcome of a patient with Gaucher disease type III treated by enzymatic replacement therapy.
    Dobbelaere D; Sukno S; Defoort-Dhellemmes S; Lamblin MD; Largillière C
    J Inherit Metab Dis; 1998 Feb; 21(1):74-6. PubMed ID: 9501273
    [No Abstract]   [Full Text] [Related]  

  • 26. Hematologic response in type I Gaucher's disease after enzyme replacement therapy.
    Parco S; Bruno G; Durighello M; Giorgini R; Simeone R; Bembi B
    Haematologica; 1999 Apr; 84(4):376-7. PubMed ID: 10190956
    [No Abstract]   [Full Text] [Related]  

  • 27. Enzyme replacement in Gaucher disease.
    Beutler E
    PLoS Med; 2004 Nov; 1(2):e21. PubMed ID: 15578103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interruption in enzyme replacement therapy for Gaucher disease.
    Weinreb NJ
    Br J Haematol; 2001 Jun; 113(4):1087-9. PubMed ID: 11442515
    [No Abstract]   [Full Text] [Related]  

  • 29. [A retrospective study on enzyme replacement therapy in patients with Gaucher disease].
    Duan YL; Zhang YH; Zang Y; Shi HP; Zhang WM; Hu YM
    Zhonghua Er Ke Za Zhi; 2006 Sep; 44(9):653-6. PubMed ID: 17217655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Marked clinical and histologic improvement in a patient with type-1 Gaucher's disease following long-term glucocerebroside substitution. A case report and review of current diagnosis and management.
    Heukamp LC; Schröder DW; Plassmann D; Homann J; Büttner R
    Pathol Res Pract; 2003; 199(3):159-63. PubMed ID: 12812317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful rapid desensitization to imiglucerase in an adult patient with Gaucher disease and documented IgE-mediated hypersensitivity.
    Tsilochristou O; Gkavogiannakis NA; Ioannidou EN; Makris M
    J Allergy Clin Immunol Pract; 2015; 3(4):624-6. PubMed ID: 25609344
    [No Abstract]   [Full Text] [Related]  

  • 32. Enzyme therapy in Gaucher disease type 2: an autopsy case.
    Takahashi T; Yoshida Y; Sato W; Yano T; Shoji Y; Sawaishi Y; Sakuma I; Sashi T; Enomoto K; Ida H; Takada G
    Tohoku J Exp Med; 1998 Oct; 186(2):143-9. PubMed ID: 10223617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucocerebrosidase treatment of type I Gaucher disease with severe pulmonary involvement.
    Pelini M; Boice D; O'Neil K; LaRocque J
    Ann Intern Med; 1994 Aug; 121(3):196-7. PubMed ID: 8017746
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of velaglucerase alfa enzyme replacement therapy on red blood cell properties in Gaucher disease.
    Franco M; Reihani N; Marin M; De Person M; Billette de Villemeur T; Rose C; Colin Y; Moussa F; Belmatoug N; Le Van Kim C
    Am J Hematol; 2017 Sep; 92(9):E561-E563. PubMed ID: 28621801
    [No Abstract]   [Full Text] [Related]  

  • 35. The clinical course of treated and untreated Gaucher disease. A study of 45 patients.
    Beutler E; Demina A; Laubscher K; Garver P; Gelbart T; Balicki D; Vaughan L
    Blood Cells Mol Dis; 1995; 21(2):86-108. PubMed ID: 8846048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Echocardiographic assessment of pulmonary hypertension in Gaucher's disease.
    Elstein D; Klutstein MW; Lahad A; Abrahamov A; Hadas-Halpern I; Zimran A
    Lancet; 1998 May; 351(9115):1544-6. PubMed ID: 10326537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Alglucerase treatment of type I Gaucher's disease. Preliminary results in Spain. Spanish Group on Gaucher's Disease].
    Pérez-Calvo JI; Giraldo P; Giralt M
    Sangre (Barc); 1997 Jun; 42(3):189-94. PubMed ID: 9381260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enzyme replacement therapy decreases hypergammaglobulinemia in Gaucher's disease.
    Deibener J; Kaminsky P; Jacob C; Dousset B; Klein M; Duc M
    Haematologica; 1998 May; 83(5):479-80. PubMed ID: 9658738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The uptake of recombinant glucocerebrosidases by blood monocytes from type 1 Gaucher disease patients is variable.
    Berger J; Stirnemann J; Bourgne C; Pereira B; Pigeon P; Heraoui D; Froissart R; Rapatel C; Rose C; Belmatoug N; Berger MG
    Br J Haematol; 2012 Apr; 157(2):274-7. PubMed ID: 22224474
    [No Abstract]   [Full Text] [Related]  

  • 40. Hepatocellular carcinoma in a patient with Gaucher disease on enzyme supplementation therapy.
    Erjavec Z; Hollak CE; de Vries EG
    Ann Oncol; 1999 Feb; 10(2):243. PubMed ID: 10093697
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.